CELIAC DISEASE OVERVIEW

被引:0
作者
Gojgar, Mohammed Saleh [1 ]
Fallatah, Abdulaziz Mohammed [2 ]
Tamim, Jehad Khairuddein [2 ]
Alahmadi, Ayad Yousif M. [3 ]
Hakami, Abdu Ibrahim [4 ]
Alhaddar, Noor Hameed Ali [3 ]
Homadi, Hassan Mohammad [5 ]
Alnamshah, Fahad Obaid Mohammed [6 ]
Homadi, Ibrahim Abdullah [6 ]
Albarakati, Abdulaziz Hamid [7 ]
Maddah, Abdulaziz Khalid [7 ]
Aloqpi, Fatinah Hashim [7 ]
Alnaim, Malak Meshary Husain [8 ]
机构
[1] King Fahad Gen Hosp Jeddah, Jeddah, Saudi Arabia
[2] Umm Al Qura Univ, Mecca, Saudi Arabia
[3] Jordan Univ Sci & Technol, Irbid, Jordan
[4] King Abdulaziz Univ, Jeddah, Saudi Arabia
[5] MOH, Ibn Sina Hosp, Mecca, Saudi Arabia
[6] King Khalid Univ, Abha, Saudi Arabia
[7] Ibn Sina Natl Coll Med Studies, Jeddah, Saudi Arabia
[8] Sulaiman Al Habib Hosp, Riyadh, Saudi Arabia
来源
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2019年 / 6卷 / 02期
关键词
celiac disease; pathophysiology; risk factors; epidemiology; management; TRANSGLUTAMINASE; MICROBIOTA; GENETICS; WHEAT;
D O I
10.5281/zenodo.2560722
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Introduction: Celiac disease is considered an autoimmune disease that happens in genetically predisposed individuals who get an immune reaction to gluten. The disease mainly influences the small intestine; but the clinical presentation are wide, with both intestinal and extra-intestinal symptoms. Celiac disease is noteworthy as broad clinical spectrum of presentations, large age range at which beginning can happen, and the elevated morbidity and mortality that has been shown in many studies. The disease also adds a model of an immune -based disease with both strong genetic and environmental risk factors. Aim of work: In this review, we will discuss regarding celiac disease. Methodology: We did a systematic search for celiac disease using PubMed search engine (http://www.ncbi.nlm.nih.gov/) and Google Scholar search engine (https://scholar.google.com). All relevant studies were retrieved and discussed. We only included full articles. Conclusions: In spite of the increase in the prevalence of celiac disease and enhanced recognition and numbers of diagnosis, many avenues of investigation are necessary to understand the pathogenesis and enhanced the management of patients with this condition. Enhancements in the pathophysiology of celiac disease may let preventive techniques in individuals at high risk for disease development. The development of non-dietary therapies may relieve symptoms in patients with celiac disease and inadvertent gluten exposure, and an effective alternative of the gluten-free diet could greatly enhance the quality of life of those many patients who find adhering to the diet very difficult. advances for the detection of gluten in food and to examine for recent gluten exposure may enhance the design of future clinical trials and may be of critical value in patients daily activities.
引用
收藏
页码:3338 / 3343
页数:6
相关论文
共 20 条
  • [1] Does celiac disease occur in Afro-derived Brazilian populations?
    Almeida, Rodrigo C.
    Gandolfi, Lenora
    Klautau-Guimaraes, Maria de Nazare
    Ferrari, Iris
    Sousa, Sandra M. B.
    Abe-Sandes, Kiyoko
    Barbosa, Ana A. L.
    Simoes, Aguinaldo L.
    Pratesi, Riccardo
    Oliveira, Silviene F.
    [J]. AMERICAN JOURNAL OF HUMAN BIOLOGY, 2012, 24 (05) : 710 - 712
  • [2] Trends and Racial/Ethnic Disparities in Gluten-Sensitive Problems in the United States: Findings from the National Health and Nutrition Examination Surveys From 1988 to 2012
    Choung, Rok Seon
    Ditah, Ivo C.
    Nadeau, Ashley M.
    Rubio-Tapia, Alberto
    Marietta, Eric V.
    Brantner, Tricia L.
    Camilleri, Michael J.
    Rajkumar, S. Vincent
    Landgren, Ola
    Everhart, James E.
    Murray, Joseph A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (03) : 455 - 461
  • [3] Identification of tissue transglutaminase as the autoantigen of celiac disease
    Dieterich, W
    Ehnis, T
    Bauer, M
    Donner, P
    Volta, U
    Riecken, EO
    Schuppan, D
    [J]. NATURE MEDICINE, 1997, 3 (07) : 797 - 801
  • [4] Downey L, 2015, BMJ-BRIT MED J, V351, P4513
  • [5] Intestinal Microbiota Modulates Gluten-Induced Immunopathology in Humanized Mice
    Galipeau, Heather J.
    McCarville, Justin L.
    Huebener, Sina
    Litwin, Owen
    Meisel, Marlies
    Jabri, Bana
    Sanz, Yolanda
    Murray, Joseph A.
    Jordana, Manel
    Alaedini, Armin
    Chirdo, Fernando G.
    Verdu, Elena F.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (11) : 2969 - 2982
  • [6] Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey
    Gray, Alastair M.
    Papanicolas, Irene N.
    [J]. BMC HEALTH SERVICES RESEARCH, 2010, 10
  • [7] Specific Nongluten Proteins of Wheat Are Novel Target Antigens in Celiac Disease Humoral Response
    Huebener, Sina
    Tanaka, Charlene K.
    Uhde, Melanie
    Zone, John J.
    Vensel, William H.
    Kasarda, Donald D.
    Beams, Leilani
    Briani, Chiara
    Green, Peter H. R.
    Altenbach, Susan B.
    Alaedini, Armin
    [J]. JOURNAL OF PROTEOME RESEARCH, 2015, 14 (01) : 503 - 511
  • [8] Epidemic of coeliac disease in Swedish children
    Ivarsson, A
    Persson, LÅ
    Nyström, I
    Ascher, H
    Cavell, B
    Danielsson, L
    Dannaeus, A
    Lindberg, T
    Lindquist, B
    Stenhammar, L
    Hernell, O
    [J]. ACTA PAEDIATRICA, 2000, 89 (02) : 165 - 171
  • [9] Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4
    Junker, Yvonne
    Zeissig, Sebastian
    Kim, Seong-Jun
    Barisani, Donatella
    Wieser, Herbert
    Leffler, Daniel A.
    Zevallos, Victor
    Libermann, Towia A.
    Dillon, Simon
    Freitag, Tobias L.
    Kelly, Ciaran P.
    Schuppan, Detlef
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (13) : 2395 - 2408
  • [10] HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer:: Results from the European genetics cluster on celiac disease
    Karell, K
    Louka, AS
    Moodie, SJ
    Ascher, H
    Clot, F
    Greco, L
    Ciclitira, PJ
    Sollid, LM
    Partanen, J
    [J]. HUMAN IMMUNOLOGY, 2003, 64 (04) : 469 - 477